Key result
Coronary microvascular dysfunction explains persistent cardiac symptoms after COVID-19 without epicardial stenoses.
Why the study?
Approximately 30% of patients with post-acute sequelae of SARS-CoV-2 report chest pain or dyspnoea, but no comprehensive concept regarding pathophysiology or treatment exists. This article reviews basic and clinical evidence for the hypothesis that coronary microvascular dysfunction may explain cardiac symptoms in these patients.
This review highlights coronary microvascular dysfunction as a plausible underlying mechanism for persistent angina and dyspnoea in post-COVID patients without obstructive epicardial CAD, supporting guideline-directed invasive coronary function testing in this population.
Answers are grounded in this paper and cite their sources.
Supports consideration of microvascular assessment for persistent post-COVID symptoms; leaves open prospective validation before changing practice.
CA extern
No takes yet. Share an insight, caveat, or question.
Ong et al. (2026) conducted a review in Post-acute sequelae of SARS-CoV-2 (PASC / Long COVID) with cardiac symptoms in the absence of epicardial stenoses (ANOCA/INOCA). Coronary microvascular dysfunction (CMD) and coronary vasomotor disorder assessment was evaluated on Pathophysiological explanation and clinical management of cardiac symptoms in PASC. Coronary microvascular dysfunction appears to be a valid pathophysiological concept explaining persistent cardiac symptoms in the absence of epicardial stenoses in patients after COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: